Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2022 –2029 | |
|
|
USD 12.20 Billion |
| USD 21.94 Billion | |
| % | |
|
Global Bio Surgical Agents Market, By Product (Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agent, Surgical Sealants and Adhesives, Adhesion Barriers, Staple-Line Reinforcement Agents), Application (General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurological Surgery, Reconstructive Surgery, Gynecological Surgery, Thoracic Surgery, Urological Surgery) – Industry Trends and Forecast to 2029.
According to the World Population Prospect, 2022, there will be 771 million people aged 65 and above, with this number expected to rise to 994 million by 2030 and 1.6 billion by 2050. Thus, as the geriatric population grows, so does the risk of numerous health consequences, such as increased incidences of orthopaedic and neurological problems, which can lead to biosurgery for treatment and thus drive market growth for bio surgical agents.
Data Bridge Market Research analyses that the bio surgical agents market which was USD 12.2 billion in 2021, would rocket up to USD 21.94 billion by 2029, and is expected to undergo a CAGR of 7.61% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agent, Surgical Sealants and Adhesives, Adhesion Barriers, Staple-Line Reinforcement Agents), Application (General Surgery, Cardiovascular Surgery, Orthopedic Surgery, Neurological Surgery, Reconstructive Surgery, Gynecological Surgery, Thoracic Surgery, Urological Surgery)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Medtronic (Ireland), B. Braun SE (Germany), Stryker (U.S.), Brainlab AG (Germany), Integra LifeSciences (U.S.), Scopis GmbH (Germany), Boston Scientific Corporation (U.S.), Elekta (Sweden), Cyberonics, Inc. (U.S.), Micromar Ind. e Com. LTDA (Spain), Neuros Medical (U.S.), SPR Therapeutics (U.S.), St. Jude Children's Research Hospital (U.S.), Synapse Biomedical Inc. (U.S.), KARL STORZ (Germany), Abbott (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Biosurgery is a medical procedure that involves the use of natural, synthetic or semi-synthetic materials to seal surgical incisions and wounds. It is frequently used to stop uncontrollable bleeding, provide adhesion for sealing wounds or tissues, and mend broken bones and tissues. Typically, biosurgeries are carried out using a variety of hemostatic, sealant, soft tissue healing, bone graft replacement, adhesion prevention, and staple line reinforcing materials.
Drivers
The market's expansion is primarily being fuelled by factors such as the rising prevalence of surgeries, particularly sports-related and trauma surgeries, the rising demand for technologically advanced surgical procedures, and the expanding use of minimally invasive procedures globally.
Opportunities
The use of bio surgery products is spreading in developing nations, particularly in the Asia-Pacific region, Latin America, the Middle East, and Africa. Players in the bio surgical agents market could have a lot of growth potential in the upcoming years in nations like China, India, and Brazil. This is due to the markets in these nations being marked by a sizable patient base for the target indications (such as cardiovascular, orthopaedic, general/abdominal, and gynaecological disorders), rising health awareness, growing healthcare expenditure, rising medical tourism, and quickly developing healthcare infrastructure.
Restraints/Challenges
On the other hand, the high cost, coupled with the unfavourable reimbursement scenario for these products in emerging countries, makes them unaffordable for a large section of the target patient population will obstruct the market's growth rate.
This bio surgical agents market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the bio surgical agents market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Hospitals became high-risk areas because of the rising COVID-19 prevalence, especially for patients with chronic illnesses. As a result, non-critical procedures like elective surgeries were either abandoned or delayed during the first and second quarters of 2020, which led to a significant drop in the overall volume of elective surgical procedures carried out. As a result, 2020 saw a substantial fall in the market for items used in biosurgery. Elective surgical operations were further deprioritized by COVID-19's second wave. Additionally, restrictions and bans on medical treatments and elective surgeries have been enacted by governments all over the world.
Recent Development
The bio surgical agents market is segmented on the basis of product type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
Application
The bio surgical agents market is analysed and market size insights and trends are provided by country, product type, application and end-user as referenced above.
The countries covered in the bio surgical agents market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the bio surgical agents market due to the largest market size. It is because of the presence of well-developed healthcare system.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the rising health awareness among the people and growing demand of advanced medical technology.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The bio surgical agents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bio surgical agents market.
Some of the major players operating in the bio surgical agents market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.